160 related articles for article (PubMed ID: 27821212)
1. Neurofibromatosis Clinic: A Report on Patient Demographics and Evaluation of the Clinic.
Mansouri A; Ghadakzadeh S; Maqbool T; Barnett C; Au K; Kongkham P; Bril V; Gelareh Z
Can J Neurol Sci; 2017 Sep; 44(5):577-588. PubMed ID: 27821212
[TBL] [Abstract][Full Text] [Related]
2. Increasing access to specialty care for rare diseases: a case study using a foundation sponsored clinic network for patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis.
Merker VL; Dai A; Radtke HB; Knight P; Jordan JT; Plotkin SR
BMC Health Serv Res; 2018 Aug; 18(1):668. PubMed ID: 30157837
[TBL] [Abstract][Full Text] [Related]
3. Retrospective analysis of patients attending a neurofibromatosis type 1 clinic.
Noble F; Kornberg AJ; Elder JE; Delatycki MB
J Paediatr Child Health; 2007; 43(1-2):55-9. PubMed ID: 17207057
[TBL] [Abstract][Full Text] [Related]
4. [Children with neurofibroma type 1 treated in the Children's Memorial Health Institute].
Perek-Polnik M; Filipek I; Dembowska-Bagińska B; Owsik A; Drogosiewicz M; Jurkiewicz E; Perek D
Med Wieku Rozwoj; 2006; 10(3 Pt 1):699-709. PubMed ID: 17317901
[TBL] [Abstract][Full Text] [Related]
5. Fractures in children with neurofibromatosis type 1 from two NF clinics.
George-Abraham JK; Martin LJ; Kalkwarf HJ; Rieley MB; Stevenson DA; Viskochil DH; Hopkin RJ; Stevens AM; Hanson H; Schorry EK
Am J Med Genet A; 2013 May; 161A(5):921-6. PubMed ID: 23529831
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of neurofibromatosis type 1 in congenital pseudarthrosis of the tibia.
Van Royen K; Brems H; Legius E; Lammens J; Laumen A
Eur J Pediatr; 2016 Sep; 175(9):1193-1198. PubMed ID: 27519821
[TBL] [Abstract][Full Text] [Related]
7. Neurosurgical contribution within a complex NF1 supraregional service.
Raffalli-Ebezant H; George KJ; Burkitt-Wright E; Roncaroli F; Evans G; Soh C; Ealing J; Vassallo G; Elloo JE; Karabatsou K
Clin Neurol Neurosurg; 2019 May; 180():18-24. PubMed ID: 30870761
[TBL] [Abstract][Full Text] [Related]
8. Seizures in children with neurofibromatosis type 1: is neurofibromatosis type 1 enough?
Santoro C; Bernardo P; Coppola A; Pugliese U; Cirillo M; Giugliano T; Piluso G; Cinalli G; Striano S; Bravaccio C; Perrotta S
Ital J Pediatr; 2018 Mar; 44(1):41. PubMed ID: 29566708
[TBL] [Abstract][Full Text] [Related]
9. [Neurofibromatosis type 1 or Von Recklinghausen's disease].
Pinson S; Wolkenstein P
Rev Med Interne; 2005 Mar; 26(3):196-215. PubMed ID: 15777582
[TBL] [Abstract][Full Text] [Related]
10. Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients.
Friedman JM; Birch PH
Am J Med Genet; 1997 May; 70(2):138-43. PubMed ID: 9128932
[TBL] [Abstract][Full Text] [Related]
11. Associations between allergic conditions and pediatric brain tumors in Neurofibromatosis type 1.
Porcelli B; Zoellner NL; Abadin SS; Gutmann DH; Johnson KJ
Fam Cancer; 2016 Apr; 15(2):301-8. PubMed ID: 26666764
[TBL] [Abstract][Full Text] [Related]
12. Role, function and challenges of multidisciplinary centres for rare diseases exemplified for neurofibromatosis type 1 syndrome.
Toledano-Alhadef H; Mautner VF; Gugel I; Zipfel J; Haas-Lude K; Constantini S; Schuhmann MU
Childs Nerv Syst; 2020 Oct; 36(10):2279-2284. PubMed ID: 32514759
[TBL] [Abstract][Full Text] [Related]
13. Epileptic seizures in neurofibromatosis type 1 are related to intracranial tumors but not to neurofibromatosis bright objects.
Hsieh HY; Fung HC; Wang CJ; Chin SC; Wu T
Seizure; 2011 Oct; 20(8):606-11. PubMed ID: 21621428
[TBL] [Abstract][Full Text] [Related]
14. Association of sociodemographic and clinical factors with the quality of life of Brazilian individuals with Neurofibromatosis type 1: a cross-sectional study.
Bicudo NP; Germano CMR; de Moraes RT; de Avó LRDS; Ferner RE; Melo DG
An Bras Dermatol; 2024; 99(4):520-526. PubMed ID: 38493052
[TBL] [Abstract][Full Text] [Related]
15. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1.
Ferner RE; Huson SM; Thomas N; Moss C; Willshaw H; Evans DG; Upadhyaya M; Towers R; Gleeson M; Steiger C; Kirby A
J Med Genet; 2007 Feb; 44(2):81-8. PubMed ID: 17105749
[TBL] [Abstract][Full Text] [Related]
16. Speech disorders in neurofibromatosis type 1: a sample survey.
Cosyns M; Vandeweghe L; Mortier G; Janssens S; Van Borsel J
Int J Lang Commun Disord; 2010; 45(5):600-7. PubMed ID: 19900076
[TBL] [Abstract][Full Text] [Related]
17. Neurofibromatosis type 1 clinical features and management.
Scalzone M; Coccia P; Ruggiero A; Riccardi R
Pediatr Med Chir; 2009; 31(6):246-51. PubMed ID: 20333883
[TBL] [Abstract][Full Text] [Related]
18. Lack of evidence for an association between neurofibromatosis type I and intracranial aneurysms: autopsy study and review of the literature.
Conway JE; Hutchins GM; Tamargo RJ
Stroke; 2001 Nov; 32(11):2481-5. PubMed ID: 11692004
[TBL] [Abstract][Full Text] [Related]
19. Establishment of in-hospital clinical network for patients with neurofibromatosis type 1 in Nagoya University Hospital.
Nishida Y; Ikuta K; Natsume A; Ishihara N; Morikawa M; Kidokoro H; Muramatsu Y; Nonobe N; Ishizuka K; Takeichi T; Kanbe M; Mizuno S; Imagama S; Ozaki N
Sci Rep; 2021 Jun; 11(1):11933. PubMed ID: 34099792
[TBL] [Abstract][Full Text] [Related]
20. Uptake of health monitoring and disease self-management in Australian adults with neurofibromatosis type 1: strategies to improve care.
Crawford HA; Barton B; Wilson MJ; Berman Y; McKelvey-Martin VJ; Morrison PJ; North KN
Clin Genet; 2016 Mar; 89(3):385-91. PubMed ID: 26081173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
